1. Falsely Decreased Carbon Dioxide in Patients with Hypertriglyceridemia. (15th October 2019) Authors: Wiencek, Joesph R; Bowman, Christopher; Adams, Brad; Sussman, Craig; Sephel, Gregory; Linton, MacRae F; Nichols, James H; Woodworth, Alison Journal: Journal of applied laboratory medicine Issue: Volume 2:Number 1(2017) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Falsely Decreased Carbon Dioxide in Patients with Hypertriglyceridemia. (1st July 2017) Authors: Wiencek, Joesph R; Bowman, Christopher; Adams, Brad; Sussman, Craig; Sephel, Gregory; Linton, MacRae F; Nichols, James H; Woodworth, Alison Journal: Journal of applied laboratory medicine Issue: Volume 2:Number 1(2017) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer. (September 2019) Authors: Noor, Zorawar S.; Goldman, Jonathan W.; Lawler, William E.; Telivala, Bijoy; Braiteh, Fadi; DiCarlo, Brian A.; Kennedy, Kathleen; Adams, Brad; Wang, Xiaoyan; Jones, Benjamin; Slamon, Dennis J.; Garon, Edward B. Journal: Lung cancer Issue: Volume 135(2019) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09). (November 2018) Authors: Hurvitz, Sara; Singh, Rashi; Adams, Brad; Taguchi, Julie A.; Chan, David; Dichmann, Robert A.; Castrellon, Aurelio; Hu, Eddie; Berkowitz, Jonathan; Mani, Aruna; DiCarlo, Brian; Callahan, Rena; Smalberg, Ira; Wang, Xiaoyan; Meglar, Ivana; Martinez, Diego; Hobbs, Evthokia; Slamon, Dennis J. Journal: Therapeutic advances in medical oncology Issue: Volume 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus. (November 2020) Authors: Peddi, Parvin F.; Tetef, Merry; Coluzzi, Paul; Arzoo, Karo K.; Hu, Eddie H.; Berkowitz, Maurice J.; Chan, David; Moore, Dennis; Adams, Brad; Wang, Xiaoyan; Hurvitz, Sara A. Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. (September 2018) Authors: Garon, Edward B.; Siegfried, Jill M.; Stabile, Laura P.; Young, Patricia A.; Marquez-Garban, Diana C.; Park, David J.; Patel, Ravi; Hu, Eddie H.; Sadeghi, Saeed; Parikh, Rupesh J.; Reckamp, Karen L.; Adams, Brad; Elashoff, Robert M.; Elashoff, David; Grogan, Tristan; Wang, He-Jing; Dacic, Sanja; ... Journal: Lung cancer Issue: Volume 123(2018) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗